Skip to main content
. 2021 May 25;16:1415–1424. doi: 10.2147/COPD.S298678

Figure 1.

Figure 1

Heat map presenting concentrations of selected eicosanoids.

Notes: (A) Healthy controls, (B) COPD subjects with noneosinophilic airway inflammation, (C) COPD subjects with eosinophilic airway inflammation.